Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewTB 21007 is a GABAA receptor inverse agonist selective for the α5-subtype (Ki values are 1.6, 16, 20 and 20 nM for α5, α2, α1 and α3 subtypes respectively). Brain penetrant; enhances cognitive performance in rats in the delayed matching-to-place morris water maze test following i.p. administration.
M. Wt | 339.5 |
Formula | C15H17NO2S3 |
Storage | Store at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 207306-50-1 |
PubChem ID | 6918633 |
InChI Key | QILRYFCEXLFIDS-UHFFFAOYSA-N |
Smiles | O=C2C1=C(SCCO)SC(C3=NC=CS3)=C1CC(C)(C)C2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 33.95 | 100 | |
ethanol | 8.49 | 25 |
The following data is based on the product molecular weight 339.5. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.95 mL | 14.73 mL | 29.46 mL |
5 mM | 0.59 mL | 2.95 mL | 5.89 mL |
10 mM | 0.29 mL | 1.47 mL | 2.95 mL |
50 mM | 0.06 mL | 0.29 mL | 0.59 mL |
References are publications that support the biological activity of the product.
Chambers et al (2003) Identification of a novel, selective GABA5 α5 receptor inverse agonist which enhances cognition. J.Med.Chem. 46 2227 PMID: 12747794
If you know of a relevant reference for TB 21007, please let us know.
Keywords: TB 21007, TB 21007 supplier, α5, alpha5-selective, GABAA, inverse, agonists, Receptors, TB21007, 2905, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for TB 21007 include:
De la Luz-Cuellar et al (2019) Blockade of spinal α5-GABAA receptors differentially reduces reserpine-induced fibromyalgia-type pain in female rats. Eur J Pharmacol 858 172443 PMID: 31181208
Koh et al (2013) Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment. J Clin Invest 64 145 PMID: 22732440
Do you know of a great paper that uses TB 21007 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review TB 21007 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Written by Ian Martin, Norman Bowery and Susan Dunn, this review provides a history of the GABA receptor, as well as discussing the structure and function of the various subtypes and the clinical potential of receptor modulators; compounds available from Tocris are listed.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.